Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Advanced Cholangiocarcinoma
NCT00973713Phase 2Unknown
- Sponsor
- Austin Health
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in cholangiocarcinoma (CCA), sponsored by Austin Health. Status: unknown.
02
Drugs
everolimus
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00973713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973713.